Clinical Trial: Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil Treatment of Advanced Primary Liver Cancer After TACE

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title: An Randomized and Controlled Study of Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil Treatment of Advanced Primary Liver Cancer After TACE

Brief Summary: To investigate the therapy effect and security of oxaliplatin and fluorouracil on with or without concomitant vascular invasion and extrahepatic metastases unresectable advanced primary liver cancer

Detailed Summary:
Sponsor: Zhu Xu

Current Primary Outcome: Progression-free survival (PFS) [ Time Frame: three years ]

Original Primary Outcome: Same as current

Current Secondary Outcome: overall survival (OS) [ Time Frame: three years ]

Original Secondary Outcome: Same as current

Information By: Beijing Cancer Hospital

Dates:
Date Received: September 22, 2015
Date Started: January 2015
Date Completion: December 2017
Last Updated: September 22, 2015
Last Verified: July 2015